Pharmacokinetics and tolerability of semaglutide in people with hepatic impairment

AIMS: To investigate whether the pharmacokinetic characteristics of semaglutide were altered in people with hepatic impairment, assessed using Child–Pugh criteria, vs those with normal hepatic function. METHODS: In this multicentre, open‐label, parallel‐group trial (sponsor Novo Nordisk, ClinicalTri...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Diabetes Obes Metab
Prif Awduron: Jensen, Lene, Kupcova, Viera, Arold, Gerhard, Pettersson, Jonas, Hjerpsted, Julie B.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Blackwell Publishing Ltd 2018
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5873441/
https://ncbi.nlm.nih.gov/pubmed/29205786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13186
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg